PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients
Kleiburg, F., de Geus-Oei, L.F., Luelmo, S.A.C., Spijkerman, R., Goeman, J.J., Toonen, F.A.J., Smit, F., van der Hulle, T., Heijmen, L.
Published in European journal of radiology (01.12.2024)
Published in European journal of radiology (01.12.2024)
Get full text
Journal Article